2 studies found for:    23769235 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia
Condition: HIV-1 Infection
Intervention: Drug: atazanavir 300 mg + ritonavir 100 mg + dolutegravir 50 mg
2 Completed
Has Results
A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 2N(t)RTI;   Drug: Ritonavir-boosted lopinavir

Indicates status has not been verified in more than two years